Bioanalysis of recombinant proteins and antibodies by mass spectrometry
Literature Information
Publication Date
2009-03-24
DOI
10.1039/B819706G
Impact Factor
4.616
Authors
Eric Ezan, Mathieu Dubois, François Becher
View Original
Abstract
In recent years, biotechnologically-derived drugs have been a major focus of research and development in the pharmaceutical industry. Their pharmacokinetics and pharmacokinetic/pharmacodynamic relationships impact every stage of the development process and require their assessment in the circulation in preclinical species and in humans. To this end, immunoassays are a reference, but standardisation remains an issue owing to the restricted pattern of antibody specificity and interference with endogenous components. As an alternative, we report here analytical strategies involving liquid chromatography coupled to mass spectrometry (LC-MS) for the accurate quantification of therapeutic proteins and antibodies in biological fluids.
Related Literature
Elucidating the effect of copper as a redox additive and dopant on the performance of a PANI based supercapacitor
Kavita Pandey, Pankaj Yadav, Indrajit Mukhopadhyay
2014-11-07
Paper
DOI: 10.1039/C4CP04321A
The role of Schottky barrier in the resistive switching of SrTiO3: direct experimental evidence
Xue-Bing Yin, Zheng-Hua Tan, Xin Guo
2014-11-07
Communication
DOI: 10.1039/C4CP04151H
Re-visiting the O/Cu(111) system – when metastable surface oxides could become an issue!
Norina A. Richter, Chang-Eun Kim, Catherine Stampfl, Aloysius Soon
2014-10-28
Paper
DOI: 10.1039/C4CP04473H
Using beryllium bonds to change halogen bonds from traditional to chlorine-shared to ion-pair bonds
Ibon Alkorta, José Elguero, Otilia Mó, Manuel Yáñez, Janet E. Del Bene
2014-11-28
Paper
DOI: 10.1039/C4CP04574B
Stability and spinodal decomposition of the solid-solution phase in the ruthenium–cerium–oxide electro-catalyst
Yanmei Li, Xin Wang, Yanqun Shao, Bo Wu, Zhongzhi Tang, Wei Lin
2014-10-29
Paper
DOI: 10.1039/C4CP04131C
An experimental and theoretical study of the gas phase kinetics of atomic chlorine reactions with CH3NH2, (CH3)2NH, and (CH3)3N
J. M. Nicovich, S. Mazumder, P. L. Laine, Y. Tang, A. J. C. Bunkan, C. J. Nielsen
2014-11-11
Paper
DOI: 10.1039/C4CP03801K
Photo-induced dynamics of the heme centers in cytochrome bc1
Adrien A. P. Chauvet, André Al Haddad, Wei-Chun Kao, Frank van Mourik, Carola Hunte, Majed Chergui
2014-11-28
Paper
DOI: 10.1039/C4CP04805A
Nano-design of quantum dot-based photocatalysts for hydrogen generation using advanced surface molecular chemistry
Dalal Noureldine, Tayirjan Isimjan, Bin Lin, Silvano Del Gobbo, Mutalifu Abulikemu, Mohamed Nejib Hedhili, Dalaver H. Anjum, Kazuhiro Takanabe
2014-11-12
Paper
DOI: 10.1039/C4CP04365K
Chemical imaging of single catalyst particles with scanning μ-XANES-CT and μ-XRF-CT
S. W. T. Price, K. Ignatyev, K. Geraki, M. Basham, J. Filik, N. T. Vo, P. T. Witte, J. F. W. Mosselmans
2014-11-05
Paper
DOI: 10.1039/C4CP04488F
You might also like
Compound Q&A
What is Ethyl 3-cyclohexylpropanoate (CAS: 10094-36-7)?
Ethyl 3-cyclohexylpropanoate is a clear, colorless to light yellow liquid with a...
10094-36-7Ethyl 3-cyclohexylpr...
Compound Q&A
How should waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl)nicotinic acid (CAS: 34783-31-8) be handled?
Waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl...
34783-31-82-(Hydroxymethyl)-5-...
Compound Q&A
How should waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) be handled?
Waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) sho...
858-46-82,4,6-Tris(pentafluo...
Compound Q&A
What precautions should be taken when handling Chloroac-nle-oh (CAS: 56787-36-1)?
When handling Chloroac-nle-oh (CAS: 56787-36-1), it is essential to wear appropr...
56787-36-1Chloroac-nle-oh
Compound Q&A
What industries use Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate (CAS: 752244-05-6)?
Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate is primarily used in the...
752244-05-6Ethyl 6-phenylimidaz...
Compound Q&A
Are there alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis?
Alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis ...
55095-15-3alpha-(2-Bromophenyl...
Compound Q&A
How should waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) be handled?
Waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) should be managed...
139585-48-12-Chloro-5-methoxypy...
Compound Q&A
What industries use 1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9)?
1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9) is used in various ...
5044-27-91-(4-Methoxyphenyl)-...
Compound Q&A
Are there alternatives to 3-Bromo-5-(N-Boc)aminomethylisoxazole (CAS: 903131-45-3) in synthesis?
There are alternative reagents and compounds that can be used in the synthesis o...
903131-45-33-Bromo-5-(N-Boc)ami...
Compound Q&A
What is Tungsten(IV) oxide (CAS: 12036-22-5)?
Tungsten(IV) oxide, also known as tungsten dioxide, is a chemical compound with ...
12036-22-5Tungsten(IV) oxide
Source Journal
Analyst
CiteScore:
7.8
Self-citation Rate:
5.6%
Articles per Year:
653
Analyst publishes analytical and bioanalytical research that reports premier fundamental discoveries and inventions, and the applications of those discoveries, unconfined by traditional discipline barriers.
Recommended Compounds
![2-Bromodibenzo[b,d]furan structure](https://static.chemtradehub.com/structs/86-/86-76-0-1814.webp "2-Bromodibenzo[b,d]furan structure")
Recommended Suppliers
Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.